Finance

Beta
Lists
CTVA:NYSE
Corteva Inc
$77.46
-0.44%
(-0.34) 1D
$77.47
+0.01% (+0.010)
Pre-market
Closed: Jun 4, 4:01:54 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CTVA...
Open
$77.92
High
$78.66
Low
$76.88
Mkt. cap
51.81B
Avg. vol.
3.45M
Volume
528.00
Dividend
0.93%
Quarterly dividend
$0.18
Ex-dividend date
Jun 1, 2026
P/E ratio
45.48
52-wk high
$85.63
52-wk low
$60.54
EPS
$1.70
Beta
0.56
Shares outstanding
668.82M
No. of employees
4K
Open
$77.92
High
$78.66
Low
$76.88
Mkt. cap
51.81B
Avg. vol.
3.45M
Volume
528.00
Dividend
0.93%
Quarterly dividend
$0.18
Ex-dividend date
Jun 1, 2026
P/E ratio
45.48
52-wk high
$85.63
52-wk low
$60.54
EPS
$1.70
Beta
0.56
Shares outstanding
668.82M
No. of employees
4K
Analyst outlook
Analyst Ratings
Based on 14 analysts giving stock ratings to CTVA in the past 3 months
Buy
Buy
10
Hold
4
Sell
0
12 month forecast
Based on 14 Wall Street analysts offering 12 month price targets for CTVA in the last 3 months.
Highest
Current $77.46
$97.00 (+25.23%)
Average
$90.46 (+16.78%)
Lowest
$78.00 (+0.70%)
News stories
From sources across the web
Profile
Corteva, Inc. is an American company devoted to products for seeds and crop protection, including herbicides, insecticides, fungicides, and biologicals that are sold in 110 countries. The company's name combines "cor" with "teva". It is headquartered in Indianapolis, Indiana. Its primary brand is Pioneer Hi-Bred International. Wikipedia
About Corteva Inc
CEOChuck Magro
Employees3.52K
FoundedMar 15, 2018
Headquarters-
SectorFertilizer
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$1.50 / $1.18
+27.11%beat
Revenue / Est. (USD)
4.90B / 4.64B
+5.77%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.46B
2.62B
3.91B
4.90B
Cost of goods sold
2.93B
1.64B
2.25B
2.37B
Cost of revenue
2.93B
1.64B
2.25B
2.37B
Research and development expenses
375.00M
351.00M
413.00M
341.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.16B
731.00M
865.00M
870.00M
Operating expense
1.70B
1.24B
1.44B
1.37B
Total operating expenses
4.63B
2.89B
3.69B
3.74B
Operating income
1.83B
-270.00M
219.00M
1.16B
Other non operating income
-7.00M
-
-34.00M
-19.00M
EBT including unusual items
1.80B
-370.00M
-530.00M
858.00M
EBT excluding unusual items
1.77B
-333.00M
103.00M
1.09B
Income tax expense
422.00M
-62.00M
7.00M
133.00M
Effective tax rate
23.39%
16.76%
-1.32%
15.50%
Other operating expenses
-
-
-
-
Net income
1.31B
-320.00M
-552.00M
720.00M
Net profit margin
20.35%
-12.22%
-14.12%
14.68%
Earnings per share
2.20
-0.23
0.22
1.50
Interest and investment income
31.00M
29.00M
44.00M
34.00M
Interest expense
-52.00M
-46.00M
-46.00M
-36.00M
Net interest expenses
-21.00M
-17.00M
-2.00M
-2.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.13B
30.00M
525.00M
1.46B
Gain or loss from assets sale
-13.00M
-
-24.00M
3.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more